Sakaki, T. | Search bioRxiv

bioRxiv2024

Speed amplitude and period affect gait variability and step followability under sinusoidal speed changing conditions

BackgroundThe time courses of the joint elevation angles of the thigh, shank, and foot in one stride during walking can be well approximated by a "plane" in a triaxial space. This intersegmental coordination (IC) of the lower limb elevation angles is called planar covariation law. Thickness of the IC plane is associated with gait variability. This study aimed to examine how anteroposterior and lateral gait variabilities are influenced by sinusoidal speed changes with different amplitudes ({+/-}0.33 vs. {+/-}0.67 m{middle dot}s-1) and periods (30 vs. 60 s). We also questioned which limbs are responsible for the step variabilities in these conditions. MethodsEighteen young adults walked on a treadmill under sinusoidal speed-changing conditions with different amplitudes ({+/-}0.33 vs. {+/-}0.67 m{middle dot}s-1) and periods (30-vs. 60-s). Using 3D motion analysis system, we quantified the IC plane thickness, coefficient of variance of step width (CVSW), time delay of step length (TDSL), and step frequency (TDSF). We applied 2-way statistical parametric mapping for the time courses of each limb angle during the acceleration and deceleration phases. ResultsThe IC plane thickness was greater in the {+/-}0.67 m{middle dot}s-1 condition than in the {+/-}0.33 m{middle dot}s-1 condition. Periods and amplitudes did not affect CVSW, TDSL, and TDSF. In the middle gait cycle, the thigh and shank were delayed in the greater amplitude condition during the acceleration phase but proceeded in the same condition during the deceleration phase. DiscussionSinusoidal speed amplitude influenced anteroposterior gait variability, but not lateral gait variability, regardless of period, even in healthy young adults. More distal limbs were delayed in the greater speed amplitude condition during the acceleration phase, whereas more proximal limbs proceeded in that condition during the deceleration phase, indicating that these different behaviors of the lower limb segments could be related to step variabilities.

physiology↗

bioRxiv2018

Eldecalcitol is more effective for promoting osteogenesis than alfacalcidol in Cyp27b1-knockout Mice

Calcium (Ca) absorption from the intestinal tract is promoted by active vitamin D (1,25D3). Vitamin D not only promotes Ca homeostasis, but it also inhibits bone resorption and promotes osteogenesis, thus playing a role in the maintenance of normal bone metabolism. Because 1,25D3 plays an important role in osteogenesis, vitamin D formulations, such as alfacalcidol (ALF) and eldecalcitol (ELD), are used for treating osteoporosis. While it is known that, in contrast to ALF, ELD is an active ligand that directly acts on bone, the reason for its superior osteogenesis effects is unknown. Cyp27b1-knockout mice (Cyp27b1-/- mice) are congenitally deficient in 1,25D3 and exhibit marked hypocalcemia and high parathyroid hormone levels, resulting in osteodystrophy involving bone hypocalcification and growth plate cartilage hypertrophy. However, because the vitamin D receptor is expressed normally in Cyp27b1-/- mice, they respond normally to 1,25D3. Accordingly, in Cyp27b1-/- mice, the pharmacological effects of exogenously administered active vitamin D derivatives can be analyzed without being affected by 1,25D3. We used Cyp27b1-/- mice to characterize and clarify the superior osteogenic effects of ELD on the bone in comparison with ALF. The results indicated that compared to ALF, ELD strongly induces ECaC2, calbindin-D9k, and CYP24A1 in the duodenum, promoting Ca absorption and decreasing the plasma concentration of 1,25D3, resulting in improved osteogenesis. Because bone morphological measurements demonstrated that ELD has stronger effects on bone calcification, trabecular formation, and cancellous bone density than ALF, ELD appears to be a more effective therapeutic agent for treating postmenopausal osteoporosis, in which cancellous bone density decreases markedly. By using Cyp27b1-/- mice, this study was the first to succeed in clarifying the osteogenic effect of ELD without any influence of endogenous 1,25D3. Furthermore, ELD more strongly enhanced bone mineralization, trabecular proliferation, and cancellous bone density than did ALF. Thus, ELD is expected to show an effect on postmenopausal osteoporosis, in which cancellous bone mineral density decreases markedly.

biochemistry↗